AstraZeneca presented preliminary safety data for its pipeline drug surovatamig at the 2026 European Hematological Association conference, aiming to provide a chemotherapy-free regimen for untreated advanced follicular lymphoma. This drug, acquired from TeneoTwo, is currently being evaluated in a Phase III trial, SOUNDTRACK-F1, directly competing with Roche's Lunsumio. Both companies are vying to establish a new standard of care for follicular lymphoma, with their respective trials expected to conclude in the coming years.

The AdvisorShares Hotel ETF (BEDZ) recently experienced a significant surge in trading volume, reaching 24 times its average daily volume. This heightened activity is largely influenced by diverse AI-driven analyses concerning Carnival Corporation (a 4.4% holding within BEDZ), which present conflicting outlooks for the cruise giant. While some AI models highlight Carnival's robust post-pandemic recovery and new share buyback program, others express caution due to its substantial debt, high valuation, and vulnerability to fuel costs and economic conditions.

Benchmark Electronics has expanded its manufacturing partnership with Ouster to produce next-generation lidar sensors for automotive, industrial, robotics, and smart infrastructure uses. This expansion comes as Benchmark's stock has seen significant multi-year and year-to-date gains, though its valuation is noted as rich, trading 195.7% above its estimated fair value. Investors should monitor lidar-related revenue and margin contributions in future earnings reports, especially considering recent insider selling and current profit margins.

BJ’s Restaurants, Inc. has announced Monika Saxena as its new Brand President, effective June 3. Saxena brings over 20 years of experience from Darden Restaurants, including a significant role at LongHorn Steakhouse. This appointment comes as BJ’s Restaurants looks towards a new growth phase, despite concerns about its gross profit margins and mixed analyst opinions on its stock valuation.

Blue Bird (BLBD) stock closed up 1.85% at $72.86, outperforming the S&P 500. The company anticipates an EPS of $1.21 for the upcoming release, a 1.68% increase year-over-year, and holds a Zacks Rank of #4 (Sell). Currently, BLBD is trading at a Forward P/E ratio of 15.32, which is a discount compared to its industry's average of 19.9.

John Cornett, President of a PPL subsidiary, sold 7,051 shares of PPL Corp on June 12, 2026, reducing his total ownership to 7,768.93 shares. The company's stock was trading at $35.56, implying a market cap of $27.213 billion and a price-earnings ratio of 22.05, which is above the industry median. Based on GuruFocus's intrinsic value estimate, the stock is considered fairly valued with a price-to-GF-Value ratio of 0.98.

Anheuser-Busch is investing over $20 million to expand and modernize its St. Louis and Arnold facilities to boost Michelob ULTRA production and upgrade packaging. This move highlights the low-carb beer's critical role in the brewer's U.S. portfolio and is part of a larger $600 million "Brewing Futures" initiative. The investment aims to increase output, improve efficiency, and develop a skilled workforce to support the brand's continued growth in the light beer segment.

Memorial Sloan Kettering Cancer Center has filed a patent infringement lawsuit against GE HealthCare, alleging that GE's MotionFree respiratory motion-correction technology infringes on six imaging patents developed by an MSK physicist. The lawsuit, filed in Delaware, claims GE HealthCare's software and PET/CT systems utilize MSK's patented methods for retrospective internal gating, which improves image quality by correcting for patient motion without external devices. MSK is seeking damages, including a reasonable royalty, and enhanced damages for willful infringement.

Paychex is enhancing its flagship Paychex Flex cloud platform for mid-sized U.S. businesses with deeper analytics and integrations, aiming to consolidate payroll, HR, and benefits management. These updates target an intensifying competitive landscape in HR software by providing a unified, data-driven approach to workforce planning. The platform, used by over 740,000 payroll clients, emphasizes compliance automation and integrations with popular ERPs, further solidifying Paychex's position in the work technology ecosystem.

ServiceNow (NOW) stock jumped 4.6% today after a peace deal announced by the Trump administration led to a drop in treasury yields. This geopolitical development improved the valuation outlook for software companies, which are sensitive to long-term interest rates. The market views this news as meaningful, although ServiceNow's stock has seen significant volatility recently, including a 5% drop 10 days ago due to a strong jobs report suggesting higher-for-longer interest rates.